ICON Public Limited Company (ICLR) News
Follow ICON Public Limited Company (ICLR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 37 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Form SCHEDULE 13G/A ICON PLC Filed by: FMR LLC
Filed on: November 5, 20
EQUITY | Nov 05, 2026, 06:20 PM UTC
M
Analysts Raise Price Targets for ICON After Q3 Earnings
Deutsche Bank raised its ICON target to $250 from $200, RBC to $226 from $185, and Truist Securities to $268 from $209. All three firms maintained their existing Buy or Outperform ratings.
EQUITY | Oct 29, 2026, 02:03 PM UTC
M
Icon reports third-quarter net income
Icon PLC reported third-quarter net income.
EQUITY | Oct 28, 2026, 06:38 PM UTC
M
ICLR Reports Fiscal Q3 Profit, Up 273.65% Year Over Year
ICLR reported fiscal 2026 third-quarter profit attributable to shareholders up 273.65% year over year, with basic EPS also reported.
EQUITY | Oct 28, 2026, 05:10 AM UTC
M
Icon shares rise after third-quarter profit beat
Shares of contract research firm Icon rose after it beat profit expectations for the third quarter.
EARNINGS | Oct 27, 2026, 09:50 PM UTC
M
ICON Q3 Non-GAAP Earnings and Revenue Fall; 2026 Guidance Rises
ICON reported Q3 non-GAAP net income, while its headline says earnings and revenue fell and 2026 guidance was lifted.
EQUITY | Oct 27, 2026, 09:24 PM UTC
M
ICON Sets FY Revenue Outlook at USD 8,100–8,200 Million
ICON set its full-year revenue outlook at USD 8,100–8,200 million.
EARNINGS | Oct 27, 2026, 09:22 PM UTC
M
ICON Returns to Profit in Q3 2026
ICON reported a profit in the third quarter of 2026, compared with a loss in the same period a year earlier.
EARNINGS | Oct 27, 2026, 09:06 PM UTC
M
ICON Q3 Adjusted EBITDA $336.9 Million vs. IBES Estimate
ICON reported Q3 adjusted EBITDA of $336.9 million, compared with the IBES estimate of $332.6 million.
EARNINGS | Oct 27, 2026, 08:59 PM UTC
M
ICON Board Approves Increase in Share Repurchase Authorization to $750M
ICON's board approved an increase in the total value of authorized share repurchases to $750 million.
EQUITY | Oct 27, 2026, 08:45 PM UTC
M
ICON Reports Third-Quarter Revenue of $2.02 Billion
EQUITY | Oct 27, 2026, 08:44 PM UTC
M
ICON Q3 Adjusted EPS $2.66 vs. IBES Estimate $2.60
EARNINGS | Oct 27, 2026, 08:44 PM UTC
L
ICON reports third-quarter EPS of $1.58
EARNINGS | Oct 27, 2026, 08:43 PM UTC
L
ICON Reports Q3 Net Income of USD 122.13 Million
EARNINGS | Oct 27, 2026, 08:43 PM UTC
M
ICON Reports Q3 Revenue of USD 2,024.757 Million
Q3 revenue was USD 2,024.757 million versus the IBES estimate of USD 2,015 million.
EQUITY | Oct 27, 2026, 08:43 PM UTC
M
ICON Reports Third-Quarter 2026 Results
ICON reported its third-quarter 2026 results. The supplied body excerpt notes net business wins but is truncated.
EQUITY | Oct 27, 2026, 08:43 PM UTC
M
ICON schedules Q3 2026 earnings call for Oct. 27
ICON plc said it will release its Q3 2026 results after the market closes Tuesday, Oct. 27, and hold a conference call and webcast to discuss them.
EQUITY | Oct 08, 2026, 12:01 PM UTC
H
TDOC -24.5%, CVNA -15.2%, TREE -12.1%, HLI -11.5%, WAY -8.1%, CWH -7.4%, ALGN -7.2%, WWD -6.7%, LXU -6.6%, META -6.4%, ALKT -5.3%, COUR -5.3
TDOC -24.5%, CVNA -15.2%, TREE -12.1%, HLI -11.5%, WAY -8.1%, CWH -7.4%, ALGN -7.2%, WWD -6.7%, LXU -6.6%, META -6.4%, ALKT -5.3%, COUR -5.3%, MX -3.6%, QCOM -3.6%, PFSI -3.3%, PDFS -3.1%, HOOD -2.9%, ORLY -2.8%, ICLR -2
EARNINGS | Jul 29, 2026, 08:44 PM UTC
H
PRCH +20%, CORT +18.3%, BOOM +17.3%, FORM +16.4%, SBUX +10.2%, FTNT +9.4%, BHE +9.3%, LUNG +8.8%, LRCX +7.6%, CMG +7.1%, GKOS +7%, GFL +5.7%
PRCH +20%, CORT +18.3%, BOOM +17.3%, FORM +16.4%, SBUX +10.2%, FTNT +9.4%, BHE +9.3%, LUNG +8.8%, LRCX +7.6%, CMG +7.1%, GKOS +7%, GFL +5.7%, RGR 4.8%, MOD +3.9%, ICLR +3.8%, ST +3.6%, MAX +2.6%, EQIX +2.4% after results
EARNINGS | Jul 29, 2026, 08:27 PM UTC
L
Icon Affirms FY2026 Adj EPS Guidance of $10.00-$11.00 vs $10.64 Est; Affirms FY2026 Sales Guidance of $7.850B-$8.150B vs $8.063B Est
Icon (NASDAQ: ICLR ) affirms FY2026 Adj EPS guidance from $10.00-$11.00 to $10.00-$11.00 vs $10.64 analyst estimate. Affirms FY2026 sales outlook from $7.850 billion-$8.150 billion to $7.850 billion-$8.150 billion vs $8.
EARNINGS | Jul 29, 2026, 08:23 PM UTC
L
ICLR Icon RESULTS: Q2, Q2 Net Income $72.582M, Q2 REV $2,063.486M vs. EST $2.006B, Q2 pretax profit $92.197M vs. EST $228.6M, Q2 Operating I
ICLR Icon RESULTS: Q2, Q2 Net Income $72.582M, Q2 REV $2,063.486M vs. EST $2.006B, Q2 pretax profit $92.197M vs. EST $228.6M, Q2 Operating Income $137.829M vs. EST $270.5M, Q2 ADJ EBITDA $327.2M vs. EST $322.4M, Q2 ADJ E
EARNINGS | Jul 29, 2026, 08:21 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
H
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95as midpoint tops ests $12.90; posted Q2 EPS and rev beat $4.37B vs. est. $4.3B -
EARNINGS | Jul 28, 2026, 12:48 PM UTC
L
ICLR - ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
ICLR - ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
EQUITY | Jul 28, 2026, 11:07 AM UTC
L
ICLR Icon announces multi-year collaboration with anthropic to bring Frontier AI to clinical trials Icon - Co and anthropic to accelerate cl
ICLR Icon announces multi-year collaboration with anthropic to bring Frontier AI to clinical trials Icon - Co and anthropic to accelerate clinical development innovation with advanced technologies - To develop site Intel
EQUITY | Jul 28, 2026, 11:03 AM UTC
L
Truist Securities Upgrades Icon to Buy, Raises Price Target to $207
Truist Securities analyst Jailendra Singh upgrades Icon (NASDAQ: ICLR ) from Hold to Buy and raises the price target from $159 to $207.
EQUITY | Jun 30, 2026, 01:52 PM UTC
M
ICLR: TD Cowen Raises PT
TD Cowen analyst Charles Rhyee maintains Icon with a Buy and raises the price target from $164 to $197
EQUITY | Jun 25, 2026, 02:46 PM UTC
M
ICLR: Evercore Raises Target
Evercore ISI Group raises Icon's price target to $180 and maintains Outperform rating
EQUITY | Jun 25, 2026, 01:54 PM UTC
H
Analysts Cut/Boost Targets
Top Wall Street analysts change outlook on several stocks, including Micron, Nike, and PepsiCo, with price target cuts and boosts
EQUITY | Jun 25, 2026, 01:06 PM UTC
H
KB Home Beats Q2 Sales
KB Home reports Q2 revenue of $1.11 billion, beating analyst estimates, and earnings of 43 cents per share, missing estimates
EARNINGS | Jun 24, 2026, 02:00 PM UTC
M
ICLR Reports Q1
Icon reports Q1 2026 results with full earnings call transcript available
EARNINGS | Jun 24, 2026, 01:26 PM UTC
H
ICLR Beats Estimates
Icon reports Q1 adjusted EPS of $2.50 and sales of $2.034B, beating estimates of $2.42 and $1.999B respectively
EARNINGS | Jun 23, 2026, 08:20 PM UTC
M
ICLR Affirms Guidance
Icon affirms FY2026 adjusted EPS guidance of $10.00-$11.00 and sales guidance of $7.850B-$8.150B
EARNINGS | Jun 23, 2026, 08:20 PM UTC
M
ICLR Beats EPS
ICLR reports EPS of $2.50, beating estimates by $0.03, with revenue in line.
EARNINGS | Jun 23, 2026, 08:16 PM UTC
H
Micron, 9 Stocks
Micron and 9 other stocks are expected to make big moves this week due to earnings volatility
EARNINGS | Jun 22, 2026, 01:25 PM UTC
M
ICLR Partners MSFT
ICON picks Microsoft to expand AI use in clinical trials
EQUITY | Jun 22, 2026, 11:15 AM UTC